Seroclearance of Hepatitis B surface antigen after entecavir treatment

被引：0
作者：
Halichidis, Stela [1 ]
Dumea, Elena [1 ]
Cambrea, Claudia S. [1 ]
机构：
[1] Clin Infect Dis Hosp, Constanta, Romania
来源：
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES | 2013年 / 22卷 / 02期
关键词：
TENOFOVIR DISOPROXIL FUMARATE; HBEAG-POSITIVE PATIENTS; ADEFOVIR DIPIVOXIL;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [41] Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989
    Mak, Lung Yi
    Wooddell, Christine, I
    Lenz, Oliver
    Schluep, Thomas
    Hamilton, James
    Davis, Heather L.
    Mao, Xianhua
    Seto, Wai-Kay
    Biermer, Michael
    Yuen, Man-Fung
    GUT, 2024, : 440 - 450
  • [42] Switching from entecavir to tenofovir alafenamide versus maintaining entecavir for chronic hepatitis B
    Hagiwara, Satoru .
    Nishida, Naoshi
    Ida, Hiroshi
    Ueshima, Kazuomi
    Minami, Yasunori
    Takita, Masahiro
    Komeda, Yoriaki
    Kudo, Masatoshi
    JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (10) : 1804 - 1810
  • [43] Hepatitis B surface antigen quantification: Clinical implications and limits in monitoring patients with chronic hepatitis B
    Bouthry, E.
    Pivert, A.
    Ducancelle, A.
    Lunel-Fabiani, F.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2012, 27 (06): : 332 - 338
  • [44] Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection
    Wen, Wan-Hsin
    Huang, Chi-Wen
    Chie, Wei-Chu
    Yeung, Chun-Yan
    Zhao, Lu-Lu
    Lin, Wen-Terng
    Wu, Jia-Feng
    Ni, Yen-Hsuan
    Hsu, Hong-Yuan
    Chang, Mei-Hwei
    Lin, Lung-Huang
    Chen, Huey-Ling
    HEPATOLOGY, 2016, 64 (05) : 1451 - 1461
  • [45] Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection
    Feld, Jordan J.
    Terrault, Norah A.
    Lin, Hsing-Hua S.
    Belle, Steven H.
    Chung, Raymond T.
    Tsai, Naoky
    Khalili, Mandana
    Perrillo, Robert
    Cooper, Stewart L.
    Ghany, Marc G.
    Janssen, Harry L. A.
    Lok, Anna S.
    HEPATOLOGY, 2019, 69 (06) : 2338 - 2348
  • [46] Serum Hepatitis B Virus RNA Levels as an Early Predictor of Hepatitis B Envelope Antigen Seroconversion During Treatment With Polymerase Inhibitors
    van Boemmel, Florian
    Bartens, Anne
    Mysickova, Alena
    Hofmann, Joerg
    Krueger, Detlev H.
    Berg, Thomas
    Edelmann, Anke
    HEPATOLOGY, 2015, 61 (01) : 66 - 76
  • [47] Effect of Pegylated Interferon Plus Tenofovir Combination on Higher Hepatitis B Surface Antigen Loss in Treatment-naive Patients With Hepatitis B e Antigen -positive Chronic Hepatitis B: A Real-world Experience
    Hu, Chengguang
    Song, Yangda
    Tang, Cuirong
    Li, Meng
    Liu, Junwei
    Liu, Jia
    Liao, Minjun
    Zhou, Fuyuan
    Zhang, Yong-Yuan
    Zhou, Yuanping
    CLINICAL THERAPEUTICS, 2021, 43 (03) : 572 - +
  • [48] Profile of HBV polymerase gene mutations during entecavir treatment in patients with chronic hepatitis B
    Sun, Mei
    Tan, Guolei
    Song, Jinyun
    Wang, Jianfang
    Wu, Xuping
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (05) : 590 - 596
  • [49] Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosis
    Gai, Xiao-Dong
    Wu, Wei-Feng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (04) : 3908 - 3914
  • [50] Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B
    Perrillo, Robert
    Buti, Maria
    Durand, Francois
    Charlton, Michael
    Gadano, Adrian
    Cantisani, Guido
    Loong, Che-Chuan
    Brown, Kimberly
    Hu, Wenhua
    Lopez-Talavera, Juan Carlos
    Llamoso, Cyril
    LIVER TRANSPLANTATION, 2013, 19 (08) : 887 - 895
12345